Paradice Investment Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39M Buy
493,906
+2,641
+0.5% +$224K 6.23% 4
2026
Q1
$42.3M Sell
491,265
-36,790
-7% -$3.3M 7.95% 1
2025
Q4
$46.1M Sell
528,055
-134,983
-20% -$10.2M 8.98% 1
2025
Q3
$38M Buy
663,038
+114,433
+21% +$6.59M 8.52% 1
2025
Q2
$32.4M Buy
548,605
+113,958
+26% +$7.36M 6.58% 5
2025
Q1
$31.8M Sell
434,647
-2,033
-0.5% -$168K 7.11% 3
2024
Q4
$36.1M Sell
436,680
-157,430
-26% -$12.4M 7.17% 2
2024
Q3
$42.5M Sell
594,110
-36,712
-6% -$2.59M 7.4% 1
2024
Q2
$43.2M Sell
630,822
-10,239
-2% -$612K 7.64% 1
2024
Q1
$34.4M Sell
641,061
-120,775
-16% -$6.49M 5.96% 3
2023
Q4
$40.6M Sell
761,836
-346,979
-31% -$16.9M 5.1% 5
2023
Q3
$55.1M Buy
+1,108,815
New +$62M 4.72% 7

Other funds holding GMED

Paradice Investment Management's GMED Position: Q2 2026 in Review

Paradice Investment Management increased its Globus Medical (GMED) stake by 0.54% in Q2 2026, buying an estimated $224K and bringing the position to 493,906 shares worth $39M. The position accounts for 6.23% of the portfolio, ranked #4.

Paradice Investment Management first reported a position in GMED in Q3 2023 and has held it in 12 quarters since. The position peaked at $55.1M in Q3 2023. 600 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Paradice Investment Management held 493,906 shares of Globus Medical worth $39M as of Q2 2026.
  • Paradice Investment Management bought 2,641 Globus Medical shares in Q2 2026, an estimated $224K.
  • Globus Medical made up 6.23% of Paradice Investment Management's portfolio in Q2 2026, its #4 holding.
  • Paradice Investment Management first reported a position in Globus Medical in Q3 2023 and has held it in 12 quarters since.
  • Paradice Investment Management's Globus Medical position peaked at $55.1M in Q3 2023.
  • 600 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Paradice Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.